Please turn JavaScript on
Meyka - AI Powered Real Time Stock and Crypto News icon

Meyka - AI Powered Real Time Stock and Crypto News

Follow Meyka - AI Powered Real Time Stock and Crypto News's news and updates in a matter of seconds! We will deliver any update via email, phone or you can read them from here on the site on your own news page.

You can even combine different feeds with the feed for Meyka - AI Powered Real Time Stock and Crypto News.

Subscribing and unsubscribing is fast, easy and risk free.

The whole service is free of cost.

Meyka - AI Powered Real Time Stock and Crypto News: AI Powered Real Time Stock and Crypto News | Meyka

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  93.18 / day

Message History

Star Energy Group PLC (STSR) is trading at $2.62 USD on the PNK exchange with a 18.7% gain over recent months. The UK-based energy company is shifting its focus from traditional oil and gas exploration to geothermal development. With a market cap of $34.4 million and a low PE ratio of 2.08, STSR represents an...


Read full story

University of Queensland researchers have achieved a major breakthrough in solar technology by developing a safe, scalable vapour-based manufacturing process for lead-free perovskite solar cells. This innovation addresses one of the biggest barriers to commercialization: the use of toxic lead and hazardous chemicals in traditional perovskite production. Lead-free perovskite s...


Read full story

Raj Rayon Industries Limited (RAJRAYON.NS) grabbed investor attention on May 1, 2026, as trading volume exploded to 831,016 shares on the National Stock Exchange. The polyester yarn manufacturer, based in Mumbai, held steady at INR 35 despite the massive volume surge. This unusual trading activity marks a significant shift from the stock’s av...


Read full story

Bristol-Myers Squibb Company (BMY.SW) delivered a solid earnings beat on April 30, 2026, exceeding analyst expectations on both earnings and revenue. The pharmaceutical giant reported BMY.SW earnings per share of $1.26, surpassing the $1.14 estimate by 10.53%. Revenue came in at $9.18 bi...


Read full story

Bristol-Myers Squibb Company delivered a strong earnings beat on April 30, 2026, exceeding analyst expectations on both earnings and revenue fronts. The pharmaceutical giant reported earnings per share of $1.26, surpassing the $1.14 estimate by 10.53 percent. Revenue came in at $9.18 billion, beating the $8.73 billion forecast by 5.14 percent. This solid performance demonstra...


Read full story